Mayordomo, Celestino .

HRN: 27-75-73  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/25/2026
CO-AMOXICLAV 625MG (TAB)
06/25/2026
07/02/2026
ORAL
625mg
Q8
CAP
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines